This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Shenzhen Mindray Technology Announces Nominees for the Company's Second Board of Directors and Supervisory Board to APT Medical Inc. CI
Shenzhen Mindray Technology Holdings Co., Ltd. completed the acquisition of 19.72% stake in APT Medical Inc. from group of sellers. CI
APT Medical's 2023 Profit Jumps 49% MT
APT Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mindray Bio-Medical to Buy Controlling Stake in Medical Devices Maker For 6.7 Billion Yuan MT
Chinese medical device firm Mindray plans $927 million deal to control APT Medical RE
Shenzhen Mindray Technology Holdings Co., Ltd. agreed to acquire 19.72% stake in APT Medical Inc. from variou sellers for CNY6.2 billion. CI
APT Medical Forecasts Up to 58% Jump in 2023 Profit MT
Certain A Shares of APT Medical Inc. are subject to a Lock-Up Agreement Ending on 7-JAN-2024. CI
APT Medical Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
APT Medical Inc.(XSSC:688617) added to S&P Global BMI Index CI
APT Medical Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
APT Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Tranche Update on APT Medical Inc.'s Equity Buyback Plan announced on June 15, 2022. CI
Tranche Update on APT Medical Inc.'s Equity Buyback Plan announced on June 15, 2022. CI
APT Medical Inc.'s Equity Buyback announced on June 15, 2022 has expired with 311,808 shares, representing 0.47% for CNY 59.99 million. CI
APT Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Certain A Shares of APT Medical Inc. are subject to a Lock-Up Agreement Ending on 7-JAN-2023. CI
Tranche Update on APT Medical Inc.'s Equity Buyback Plan announced on June 15, 2022. CI
APT Medical Inc. announced a financing transaction CI
APT Medical Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Tranche Update on APT Medical Inc.'s Equity Buyback Plan announced on June 15, 2022. CI
APT Medical Inc. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
APT Medical Inc. announces an Equity Buyback for CNY 100 million worth of its shares. CI
APT Medical Inc.(SHSE:688617) added to Shanghai Stock Exchange Health Care Sector Index CI
Chart APT Medical Inc.
More charts
APT Medical Inc is a China-based company mainly engaged in the research and development, manufacture and sales of electrophysiological and vascular interventional medical devices. The Company's electrophysiological products include electrophysiological electrode catheters, controllable radiofrequency ablation electrode catheters and multichannel electrophysiological systems. Its coronary artery access products mainly include guide wires, micro catheters, balloons, contrast guide wires and catheters. The Company's peripheral vascular intervention products are mainly applied in peripheral vascular diseases. The Company is also engaged in related original equipment manufacturer (OEM) business. The Company distributes its products within domestic market and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
469.4 CNY
Average target price
450.4 CNY
Spread / Average Target
-4.06%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688617 Stock
  4. News APT Medical Inc.
  5. APT Medical : Soars 245% in Shanghai Trading Debut